When to Stop and Seek Medical Advice Stop immediately and consult a doctor if you experience: Severe allergic reaction (difficulty breathing, swelling of face/throat) Chest pain or heart palpitations Severe persistent headache Signs of infection at injection site (increasing redness, warmth, pus, fever) Numbness or tingling in extremities Severe gastrointestinal symptoms (persistent vomiting, blood in stool) Important disclaimers: Peptides are not FDA-approved for most consumer uses (except semaglutide/tirzepatide for weight loss/diabetes) Most are sold as "research chemicals" quality varies dramatically by source Always inform your doctor about any peptides you're using People with active cancer should avoid growth hormone-releasing peptides Pregnant or breastfeeding women should not use peptides If you drink alcohol, review how it interacts with specific peptides for example, see our BPC-157 and alcohol guide How to Minimize Risks 1

Cagrilintide is typically considered for: Adults with BMI 30 , or BMI 27 with a metabolic condition Patients who have plateaued on GLP-1 therapy Individuals with strong appetite, cravings, or binge-eating tendencies Those seeking an alternative to or enhancement of weight loss medications Who Should Avoid Cagrilintide
257 Kidney disease Autosomal dominant polycystic kidney disease (ADPKD) is a common monogenic disease characterized by the enlargement of renal cysts
If youre exploring where to begin, the Healthy Aging Supplements collection is a natural place to start
Limitations The limitations of the DSIP dosing literature are not peripheral caveats they are the main finding